Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

March 20, 2025

Study Completion Date

September 20, 2026

Conditions
Metastatic Neuroendocrine Tumour
Trial Locations (4)

42270

RECRUITING

CHU de Saint-Etienne, Hôpital Nord, Saint-Priest-en-Jarez

63011

RECRUITING

Centre de Lutte Contre le Cancer Jean Perrin, Clermont-Ferrand

69495

RECRUITING

Hospices Civils de Lyon, Hopital Lyon Sud, Lyon

73000

RECRUITING

CH Métropole Savoie, Chambéry

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER